| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_689d532e7f712c780cb4cec200f16fef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d353179e69a4fd5122c20bc05dbad5be |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91398a2209a7ed33934c522de4fbbe79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e462eab0a9656f918520f6088a8569a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f853e003388b819f825f658f3d93949e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0102fff17c4b294702207562ac6f59bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7190571e0ba44be349fd91a94d242249
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0eb828c97f73ff8397f7d1ec3c1056e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15b2cbce1eb7055ba78a516399bdece3 |
| publicationDate |
2016-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011301146-B2 |
| titleOfInvention |
Single chain relaxin polypeptides |
| abstract |
The present invention relates to biologically active single chain relaxin polypeptides comprising a relaxin B chain derived from relaxin-3, the polypeptides being truncated by one or more amino acids at the C-terminus of the relaxin-3 B chain. Typically the single chain relaxin polypeptides are antagonists of the RXFP3 receptor, and in some embodiments are selective antagonists of the RXFP3 receptor. |
| priorityDate |
2010-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |